Prospective Melanoma Database

Institut Claudius Regaud10,000 enrolled

Overview

In research on melanoma, translational research is the essential link between basic research and clinical research by facilitating the passage between discovery and improvement in the quality of patients care.That is the reason why it is very important to collect, and centralize clinical and biological data of patients with melanoma. The aim of the project is to provide to scientific community a structured, mixed clinical and biological database, unique in France, in order to insure accessibility to clinical data.

collection of clinical and biological data from patients with melanomas of any stage in a structured and centralized database

Study Type

OBSERVATIONAL

Enrollment

10,000

Conditions

Melanoma

Interventions

clinical biological data collection on melanomaOTHER

collection and centralization of clinical and biological data of patients with melanoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 years * Histologically confirmed melanoma of any stage * Affiliated to a social security system in france * Who signed the informed consent Exclusion Criteria: * Any psychiatric or medical condition that would make the patient unable to give a signed informed consent

Locations (1)

Institut claudius regaud IUCT ONCOPOLE

Toulouse, France

RECRUITING

Outcomes

Primary Outcomes

Database of patients with melanoma

Time frame: 10 years

Central Contacts

Nicolas MEYER, MD PHD

CONTACT

5 31 15 51 61 Meyer.Nicolas@iuct-oncopole.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.